Dr. Michael Bade Wheeler, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 28391 Essential Road, Merton, WI 53056 Phone: 262-538-1122 |
News Archive
Janssen Research & Development, LLC ("Janssen") today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA™ (ibrutinib) to the U.S. Food and Drug Administration (FDA) by its collaboration partner Pharmacyclics, Inc.
The Pancreatic Cancer Action Network (www.pancan.org), the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure is mourning the loss of legendary actor Patrick Swayze. His diagnosis shocked fans around the world in early 2008 and his subsequent battle put a spotlight on pancreatic cancer, the fourth leading cause of cancer death in the United States.
The increased cost and more frequent use of medical care provided to injured workers in Wisconsin drove up the average medical payments per workers' compensation claim in recent years, according to a new study by the Cambridge, Mass.-based Workers Compensation Research Institute.
The U.S. Food and Drug Administration has announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer mortality in patients who use 3 or more tubes of the product. Regranex is a topical cream indicated for the treatment of leg and foot ulcers that are not healing in diabetic patients.
News outlets report that President Barack Obama fared well in several battleground states after the political conventions, posing a challenge for GOP nominee Mitt Romney.
› Verified 8 days ago